Tradu Analyst Shares What’s Driving Metals Markets
Gold is hovering near record highs on rate-cut speculation, while copper’s role in clean tech, AI, and defense is reshaping its trajectory. At the same time, Washington has pledged nearly $1 billion to support critical minerals — highlighting both opportunity and ongoing reliance on imports. MINING.com’s Devan Murugan speaks with Tradu’s senior market analyst Nikos Tzabouras to unpack what’s driving commodities and whether market optimism may be outpacing fundamentals.
Early-Stage Biotech Gets $1.3B Boost From New Investor
Frazier Life Sciences has secured $1.3 billion for early-stage biotech investing, making it the third major firm in recent months to raise significant capital. In a market showing both resilience and selectivity, the fund highlights where opportunity and investor conviction remains strong.
Copper Prices Decline Ahead of US Tariff Deadline
After weeks of bullish momentum, copper prices reversed course on Monday amid mounting uncertainty over upcoming US tariffs. With major policy announcements and shifting trade dynamics on the horizon, the market may be entering a volatile new phase.
The next AI Giant Predicted to Overtake Nvidia
Nvidia’s $4 trillion milestone is historic, but some analysts believe another AI leader could push it even further (and faster). Here’s why it might be the better investment in today’s generative AI boom.
Ares Strategic Mining Nabs $11M for U.S. Fluorspar & Gallium Revival
Big funding. Bigger plans. Ares Strategic Mining is locking in the support it needs to become America’s only source for fluorspar (and likely gallium, too). With major moves underway at its Utah-based Lost Sheep Mine, the company has their eyes on full-scale production starting in 2025.
‘Unusually Cautious’: Biotech Dealmakers Hit the Brakes
After a quiet period for biotech M&A, dealmakers started 2025 with renewed optimism. Many expected a rebound in billion-dollar transactions, bolstered by early momentum like Johnson & Johnson’s $14.6 billion acquisition of neuroscience biotech Intra-Cellular Therapies, announced in January. Enthusiasm has since faded, with political instability and market swings cooling appetites and deepening the divide […]
GSK Q1 Strength Signals Tariff Resilience
British pharma heavyweight GSK reports a strong start to 2025 with earnings exceeding forecasts and reaffirms its growth outlook—positioning itself as a stable force even as potential U.S. pharmaceutical tariffs loom.
Why the Federal Reserve Is Holding Off on Interest Rate Cuts
While other central banks begin easing policy in response to slowing global growth, the Federal Reserve is holding firm. Concerns about inflation, unemployment, and the uncertain impact of U.S. trade policy are keeping rate cuts off the table – for now.
Should Investors Rush to Gold EFTs?
As economic uncertainty, inflation fears, and trade tensions shake investor confidence, Gold ETFs are emerging as a reliable hedge and a strategic portfolio enhancer. Learn why now may be the right time to lean into gold.
Exxon Mobil Enters the AI Power Race with a ‘Huge Advantage’
Oil and gas giant Exxon Mobil has its sights set on the surging energy market for AI-driven data centres, leveraging its expertise in carbon capture and energy infrastructure.
English 
German